(6aS,6bR,8aR,12aR,12bS,14aR,14bS)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,4,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicen-3(2H)-one

Catalog No. :
ACOCFC503
CAS No. :
508-09-8
Molecular Formula :
C30H48O
Molecular Weight :
424.71

IUPAC Name:(6aS,6bR,8aR,12aR,12bS,14aR,14bS)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,4,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicen-3(2H)-one

(6aS,6bR,8aR,12aR,12bS,14aR,14bS)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,4,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicen-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6aS,6bR,8aR,12aR,12bS,14aR,14bS)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,4,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicen-3(2H)-one
IUPAC Name(6aS,6bR,8aR,12aR,12bS,14aR,14bS)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,4,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicen-3(2H)-one
MDL No.MFCD20260715
Molecular FormulaC30H48O
Molecular Weight424.71
SMILESCC1(C)CC[C@]2(C)CC[C@]3(C)[C@H]4CC=C5[C@@H](CCC(=O)C5(C)C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1
InChI KeyXUPCBKGIPJPDGW-VZTATICASA-N
Synonymglutinone;5-Glutinen-3-one;Alnusenone;D:B-Friedoolean-5-en-3-one;Glutine;Glutinone (triterpene);25,26-Dinorolean-5-en-3-one, 9,13-dimethyl-, (8α,9β,10α,13α,14β)-
CAS No.508-09-8

Synthetic Route by SureRoute

1. ACOCFC503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOCFC503 route product structure diagram
    ACOCFC503508-09-8
Inquiry

2. ACOCFC503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOCFC503 route product structure diagram
    ACOCFC503508-09-8
Inquiry

Comments (0)